Can any of the risks of life science R & D be leveraged against government tax initiatives?
Yes, ABS Inc. claims life science R & D costs against Canadian Government tax initiatves prgramsI(i.e. SRED and IRAP) such that up to about 85% of scientiic research and development costs are refundable. Careful leveraging of these programs will maximize the effectiveness of investor capital in view of producing quality pre-clincial / clinical trials.